BG107227A - Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium - Google Patents

Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium

Info

Publication number
BG107227A
BG107227A BG107227A BG10722702A BG107227A BG 107227 A BG107227 A BG 107227A BG 107227 A BG107227 A BG 107227A BG 10722702 A BG10722702 A BG 10722702A BG 107227 A BG107227 A BG 107227A
Authority
BG
Bulgaria
Prior art keywords
calcium
mixture
vitamin
magnesium
content
Prior art date
Application number
BG107227A
Other languages
Bulgarian (bg)
Inventor
Luboslav Razus
Juraj Wendl
Ivan Varga
Petr Simek
Original Assignee
Slovakofarma, A.S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovakofarma, A.S filed Critical Slovakofarma, A.S
Publication of BG107227A publication Critical patent/BG107227A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The pharmaceutical composition with the content of calcium or mixture of calcium and vitamin D or mixture of calcium and magnesium and adjuvants in the form of instant powder which after adding a liquid form after a short mixing a pudding-like gelled suspension tolerating use by patients and having improved flavour qualities. 3 claims
BG107227A 2000-04-06 2002-10-29 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium BG107227A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK498-2000A SK284948B6 (en) 2000-04-06 2000-04-06 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin D or mixture of calcium and magnesium in a new formulation
PCT/SK2001/000004 WO2001076610A1 (en) 2000-04-06 2001-03-15 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation

Publications (1)

Publication Number Publication Date
BG107227A true BG107227A (en) 2003-05-30

Family

ID=20435843

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107227A BG107227A (en) 2000-04-06 2002-10-29 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium

Country Status (10)

Country Link
EP (1) EP1274447A1 (en)
AU (1) AU2001239668A1 (en)
BG (1) BG107227A (en)
CZ (1) CZ303069B6 (en)
EE (1) EE200200584A (en)
MD (1) MD2722B2 (en)
PL (1) PL357777A1 (en)
RU (1) RU2002130196A (en)
SK (1) SK284948B6 (en)
WO (1) WO2001076610A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
ES2370729T3 (en) 2004-05-11 2011-12-22 Egalet Ltd. INFLATABLE PHARMACEUTICAL FORM INCLUDING GELLAN RUBBER.
UA95093C2 (en) 2005-12-07 2011-07-11 Нікомед Фарма Ас Method for the preparation of calcium-containing compound
EP2410981B2 (en) 2009-03-26 2020-02-26 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
RU2011137961A (en) * 2009-03-26 2013-05-10 Пулмэтрикс, Инк. PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY INFECTIONS
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
KR101915241B1 (en) 2010-09-29 2018-11-06 풀매트릭스 오퍼레이팅 컴퍼니, 인크 Monovalent metal cation dry powders for inhalation
CA2865972C (en) 2012-02-29 2022-01-04 Pulmatrix, Inc. Inhalable dry powders
CA2907566C (en) 2013-04-01 2023-08-22 Pulmatrix, Inc. Tiotropium dry powders
JO3456B1 (en) 2015-05-13 2020-07-05 H Lundbeck As Vortioxetine pyroglutamate
RU2726438C2 (en) * 2018-11-14 2020-07-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Method for production of a dry high protein milk mixture for prevention of osteopenia in children and adolescents with gee's disease
CN109453126A (en) * 2018-12-07 2019-03-12 浙江核力欣健药业有限公司 A kind of calcium carbonate D3Composition of chewable tablets and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
CA1297035C (en) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Chewable, non-gritty calcium citrate tablet
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions
CA2143420C (en) * 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US6241997B1 (en) * 1998-03-16 2001-06-05 Smtm Group. Llc Chewable calcium supplement and method

Also Published As

Publication number Publication date
MD20020265A (en) 2003-05-31
PL357777A1 (en) 2004-07-26
EP1274447A1 (en) 2003-01-15
MD2722B2 (en) 2005-03-31
CZ303069B6 (en) 2012-03-21
SK284948B6 (en) 2006-03-02
EE200200584A (en) 2004-04-15
WO2001076610A1 (en) 2001-10-18
RU2002130196A (en) 2004-03-27
SK4982000A3 (en) 2001-10-08
AU2001239668A1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
BG107227A (en) Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium
NZ333385A (en) Solid oral dosage forms containing 35% of valsartan
MY137181A (en) Pulmonary administration of chemically modified insulin
HUP9901674A2 (en) New pharmaceutical combination
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
MX9700223A (en) Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension.
HK1050839A1 (en) Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state
MY129150A (en) Novel sulfamides
ES8608288A1 (en) A chewing gum composition, a process for preparing a chewing gum tablet therefrom, and a chewing gum tablet.
MY116272A (en) Immunity enhancing lactic acid bacteria
HUT75555A (en) Lactobacillus strains of human origin, their compositions and uses thereof
AU3259099A (en) Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
BRPI0108478B8 (en) nutritional composition containing prebiotic substances
SE8801732D0 (en) NEW COMPOSITION
HK1027751A1 (en) Pharmaceutical compositions containing vitamin D and calcium, their preparation and therapeutic use.
MXPA03004499A (en) Repinotan kit.
AU2001287850A1 (en) Iron compositions
BG105761A (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
MY140724A (en) Novel arylethene-sulfonamides
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
MD970269A (en) Clavulanates
MX9704341A (en) Food product for human or animal consumption, and a procedure for its preparation.
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
WO2002019842A3 (en) Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof